Base de dados : LILACS
Pesquisa : N04.590.607 [Categoria DeCS]
Referências encontradas : 217 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 22 ir para página                         

  1 / 217 LILACS  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Texto completo
Texto completo
Texto completo
Id: biblio-1123447
Autor: Borges, Eline Lima; Spira, Josimare Aparecida Otoni; Garcia, Taysa de Fátima.
Título: Recomendações para o manejo da úlcera da perna em pessoas com doença falciforme / Recommendations for the management of leg ulcers in people with sickle cell disease / Recomendaciones para el manejo de las úlceras de las piernas en personas con anemia de células falciformes
Fonte: Rev. enferm. UERJ;28:e50170, jan.-dez. 2020.
Idioma: en; pt.
Resumo: Objetivo: propor recomendações baseadas em evidências científicas para a prevenção e tratamento da úlcera da perna em pessoas com doença falciforme. Método: estudo de revisão integrativa, realizado a partir de busca nas bases de dados Scopus, Science Direct, Cummulative Index to Nursing and Allied Health Literature, Cochrane Library e Biblioteca Virtual em Saúde, em março de 2020. Resultados: foram publicados dez estudos entre 2010 e 2017. Extraíram-se 20 recomendações com nível de evidência classificado em muito baixo, baixo e moderado, organizadas em cinco temas: avaliação do paciente e da úlcera da perna; manejo da úlcera e do edema; utilização de coberturas no tratamento da úlcera; recomendações para manejo de úlcera recalcitrante; e autocuidado para prevenção de úlcera. Conclusão: o estudo permitiu identificar recomendações para prevenção e tratamento da úlcera da perna em pessoas com doença falciforme, que podem complementar as condutas apresentadas no manual do Ministério da Saúde a respeito do tema.

Objective: to propose scientific evidence-based recommendations for the prevention and treatment of leg ulcers in people with sickle cell disease. Method: this integrative review was performed by searching through the Scopus, Science Direct, Cumulative Index to Nursing and Allied Health Literature, Cochrane Library and Virtual Health Library databases in March 2020. Results: the ten studies found were published from 2010 to 2017. The 20 recommendations extracted offered evidence at levels rated very low, low and moderate, which was organized into five themes: evaluation of the patient and leg ulcer; management of the ulcer and edema; use of dressings in treating ulcers; recommendations for management of recalcitrant ulcers; and self-care for ulcer prevention. Conclusion: the study identified recommendations for prevention and treatment of leg ulcers in people with sickle cell disease, which can complement the conduct described in the Brazilian Ministry of Health handbook on the subject.

Objetivo: proponer recomendaciones basadas en evidencias científicas para la prevención y el tratamiento de las úlceras de pierna en personas con anemia falciforme. Método: esta revisión integradora se realizó mediante la búsqueda a través de las bases de datos Scopus, Science Direct, Cumulative Index to Nursing and Allied Health Literature, Cochrane Library y Virtual Health Library en marzo de 2020. Resultados: los diez estudios encontrados se publicaron de 2010 a 2017. 20 recomendaciones extraídas ofrecieron evidencia en niveles calificados como muy bajo, bajo y moderado, que se organizó en cinco temas: evaluación del paciente y úlcera de pierna; manejo de la úlcera y el edema; uso de apósitos para el tratamiento de úlceras; recomendaciones para el manejo de úlceras recalcitrantes; y autocuidado para la prevención de úlceras. Conclusión: el estudio identificó recomendaciones para la prevención y el tratamiento de las úlceras de pierna en personas con anemia falciforme, que pueden complementar la conducta descrita en el manual del Ministerio de Salud de Brasil sobre el tema.
Descritores: Gerenciamento Clínico
Anemia Falciforme
Úlcera da Perna/terapia
-Autocuidado
Protocolos Clínicos
Edema/terapia
Bandagens Compressivas
Limites: Humanos
Tipo de Publ: Revisão
Responsável: BR1366.1 - Biblioteca Biomédica B - CB/B (Odontologia e Enfermagem)


  2 / 217 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Id: biblio-1045648
Autor: Hermanides, HS; Busari, JO; Gerstenbluth, I; Duits, AJ.
Título: Optimizing chronic HIV care in the Dutch Caribbean: a questionnaire based study on experience and perception of healthcare workers / Optimización del cuidado del VIH crónico en el Caribe Holandés: un estudio basado en un cuestionario sobre la experiencia y la percepción de los trabajadores de la salud
Fonte: West Indian med. j;62(4):299-304, 2013. ilus, tab.
Idioma: en.
Resumo: OBJECTIVE: Human immunodeficiency virus (HIV) infection has become a chronic disorder for which adaptation of current healthcare practices is needed. In Curaçao, a new organization of chronic HIV care is being set up based on task shifting in which healthcare workers (HCWs) will deliver HIV care more prominently within the primary healthcare system. In preparation for implementation of the proposed task-shifting model, we investigated the perception of HCWs regarding existing HIV care in Curaçao and the need for training in HIV/AIDS among HCWs. SUBJECTS AND METHODS: An in-depth questionnaire based study was used. Nineteen HCWs of seven different cadres were interviewed. The questionnaire constituted four sections: quality of existing HIV care, respondents own knowledge and willingness to be trained, need for training in HIV/AIDS and preferred educational approaches. RESULTS: Quality of existing HIV services in Curaçao is considered acceptable but needs improvement mainly to facilitate integration of chronic HIV care. All respondents indicated that training in HIV/AIDS is needed among HCWs in Curaçao, especially for nurses and general practitioners. All were willing to participate in training with varying amounts of time to be spent. Training should be tailored to the level of expertise of HCWs and to the role a HCW is expected to have in the new healthcare delivery framework. CONCLUSION: There is need for training to ensure the effective integration of chronic HIV care into the existing healthcare delivery system in Curaçao. There is a willingness and need in all cadres for training with e-learning as a preferred educational tool.

OBJETIVO: La infección por virus de inmunodeficiencia humana (VIH) se ha estado convirtiendo en un trastorno crónico que requiere la adaptación de las prácticas actuales de salud. En Curazao, se ha estado creando una nueva organización de la atención del VIH crónico, basada en un cambio de tareas en las que los trabajadores de la salud (TS) brindarán un cuidado prominente al VIH dentro del sistema primario de atención a la salud. En preparación para la implementación del modelo de cambio de tareas propuesto, investigamos la percepción de los TS en relación con la atención actual al VIH en Curazao y la necesidad de capacitación en torno al VIH/SIDA entre los TS. SUJETOS Y MÉTODOS: Se utilizó un estudio basado en un cuestionario detallado. Se entrevistaron diecinueve TS de siete cuadros diferentes. El cuestionario estaba constituido por cuatro secciones: calidad del cuidado existente al VIH, conocimiento y voluntad de los propios encuestados para recibir capacitación en la atención al VIH/SIDA, y los enfoques educativos preferidos. RESULTADOS: Calidad de los servicios del VIH existentes en Curazao se considera aceptable pero necesita mejorar principalmente en cuanto a facilitar la integración de la atención del VIH crónico. Todos los encuestados indicaron que se necesita capacitación en VIH/SIDA entre los TS de Curazao, especialmente para las enfermeras y médicos generales. Todos estaban dispuestos a participar en el entrenamiento, siendo variable la cantidad de tiempo a emplear en el mismo. La capacitación se debe diseñar de acuerdo con el nivel de conocimientos de los TS, y el papel que se espera que un TS desempeñe en el nuevo marco de cuidados de la salud. CONCLUSIÓN: Hay necesidad de entrenamientos para integrar de manera efectiva la atención al VIH crónico al sistema actual de servicios de cuidados de la salud en Curazao. Todos los cuadros tienen la voluntad y la necesidad de recibir capacitación en esta área, para lo cual el aprendizaje electrónico es la herramienta educativa de preferencia.
Descritores: Qualidade da Assistência à Saúde
Atitude do Pessoal de Saúde
Infecções por HIV/tratamento farmacológico
Pessoal de Saúde/educação
-Doença Crônica
Inquéritos e Questionários
Competência Clínica/estatística & dados numéricos
Pessoal de Saúde/psicologia
Gerenciamento Clínico
Atenção à Saúde/métodos
Antilhas Holandesas
Limites: Humanos
Masculino
Feminino
Responsável: BR1.1 - BIREME


  3 / 217 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: lil-782846
Autor: Truzzi, Jose Carlos; Gomes, Cristiano Mendes; Bezerra, Carlos A; Plata, Ivan Mauricio; Campos, Jose; Garrido, Gustavo Luis; Almeida, Fernando G; Averbeck, Marcio Augusto; Fornari, Alexandre; Salazar, Anibal; Dell'Oro, Arturo; Cintra, Caio; Sacomani, Carlos Alberto Ricetto; Tapia, Juan Pablo; Brambila, Eduardo; Longo, Emilio Miguel; Rocha, Flavio Trigo; Coutinho, Francisco; Favre, Gabriel; Garcia, José Antonio; Castaño, Juan; Reyes, Miguel; Leyton, Rodrigo Eugenio; Ferreira, Ruiter Silva; Duran, Sergio; López, Vanda; Reges, Ricardo.
Título: Overactive bladder - 18 years - Part I
Fonte: Int. braz. j. urol;42(2):188-198, Mar.-Apr. 2016. tab.
Idioma: en.
Resumo: ABSTRACT Abstract: Overactive bladder syndrome is one of the lower urinary tract dysfunctions with the highest number of scientific publications over the past two decades. This shows the growing interest in better understanding this syndrome, which gathers symptoms of urinary urgency and increased daytime and nighttime voiding frequency, with or without urinary incontinence and results in a negative impact on the quality of life of approximately one out of six individuals – including both genders and almost all age groups. The possibility of establishing the diagnosis just from clinical data made patients' access to specialized care easier. Physiotherapy resources have been incorporated into the urological daily practice. A number of more selective antimuscarinic drugs with consequent lower adverse event rates were released. Recently, a new class of oral drugs, beta-adrenergic agonists has become part of the armamentarium for Overactive Bladder. Botulinum toxin injections in the bladder and sacral neuromodulation are routine modalities of treatment for refractory cases. During the 1st Latin-American Consultation on Overactive Bladder, a comprehensive review of the literature related to the evolution of the concept, epidemiology, diagnosis, and management was conducted. This text corresponds to the first part of the review Overactive Bladder 18-years.
Descritores: Bexiga Urinária Hiperativa/diagnóstico
Bexiga Urinária Hiperativa/terapia
-Qualidade de Vida
Fatores de Tempo
Fatores Sexuais
Prevalência
Gerenciamento Clínico
Bexiga Urinária Hiperativa/epidemiologia
Limites: Humanos
Masculino
Feminino
Tipo de Publ: Revisão
Responsável: BR1.1 - BIREME


  4 / 217 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: lil-777322
Autor: Tang, Kaifa; Sun, Fa; Tian, Yuan; Zhao, Yili.
Título: Management of full-length complete ureteral avulsion
Fonte: Int. braz. j. urol;42(1):160-164, Jan.-Feb. 2016. tab, graf.
Idioma: en.
Projeto: Science and Technology Project of Guizhou Province.
Resumo: ABSTRACT Introduction Complete ureteral avulsion is one of the most serious complications of ureteroscopy. The aim of this report was to look for a good solution to full-length complete ureteral avulsion. Case presentation A 40-year-old man underwent ureteroscopic management. Full-length complete avulsion of ureter occurred during ureteroscopy. Pyeloureterostomy plus greater omentum investment outside the avulsed ureter and ureterovesical anastomosis were performed 6 hours after ureteral avulsion. The patient was followed-up during 34 months. Double-J tube was removed at 3 months after operation. Twenty three months after the first operation, the patient developed hydronephrosis because of a new ureter upside stone, then rigid ureteroscopy and holmium laser lithotripsy were used successfully. Conclusion Pyeloureterostomy plus greater omentum investment outside the avulsed ureter and ureterovesical anastomosis may be a good choice for full-length complete ureteral avulsion.
Descritores: Ureter/lesões
Doenças Ureterais/cirurgia
Doenças Ureterais/etiologia
Ureterostomia/métodos
Ureteroscopia/efeitos adversos
-Omento/cirurgia
Anastomose Cirúrgica
Resultado do Tratamento
Gerenciamento Clínico
Urolitíase/cirurgia
Hidronefrose/cirurgia
Limites: Humanos
Masculino
Adulto
Tipo de Publ: Relatos de Casos
Responsável: BR1.1 - BIREME


  5 / 217 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: biblio-892867
Autor: Zequi MD, PhD, Stênio de Cássio.
Título: The Middle Term
Fonte: Int. braz. j. urol;43(4):577-578, July-Aug. 2017.
Idioma: en.
Descritores: Neoplasias da Próstata/terapia
Neoplasias da Bexiga Urinária/terapia
Gerenciamento Clínico
-Fatores de Risco
Limites: Humanos
Masculino
Feminino
Tipo de Publ: Editorial
Responsável: BR1.1 - BIREME


  6 / 217 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Chile
Texto completo
Id: biblio-950718
Autor: Acharya, Arpan; Vaniawala, Salil; Shah, Parth; Parekh, Harsh; Misra, Rabindra Nath; Wani, Minal; Mukhopadhyaya, Pratap N.
Título: A robust HIV-1 viral load detection assay optimized for Indian sub type C specific strains and resource limiting setting
Fonte: Biol. Res;47:1-8, 2014. graf, tab.
Idioma: en.
Resumo: BACKGROUND: Human Immunodeficiency Virus Type 1 (HIV-1) viral load testing at regular intervals is an integral component of disease management in Acquired Immunodeficiency Syndrome (AIDS) patients. The need in countries like India is therefore an assay that is not only economical but efficient and highly specific for HIV-1 sub type C virus. This study reports a SYBR Green-based HIV-1 real time PCR assay for viral load testing and is designed for enhanced specificity towards HIV-1 sub type C viruses prevalent in India. RESULTS: Linear regression of the observed and reference concentration of standards used in this study generated a correlation coefficient of 0.998 (p<0.001). Lower limit of detection of the test protocol was 50 copies/ml of plasma. The assay demonstrated 100% specificity when tested with negative control sera. The Spearman coefficient of the reported assay with an US-FDA approved, Taqman probe-based commercial kit was found to be 0.997. No significant difference in viral load was detected when the SYBR Green based assay was used to test infected plasma stored at -20°C and room temperature for 7 days respectively (Wilcoxon signed rank test, p=0.105). In a comparative study on 90 pretested HIV-1 positive samples with viral loads ranging from 5,000 - 25,000 HIV-1 RNA copies/ml and between two commercial assays it was found that the later failed to amplify in 13.33% and 10% samples respectively while in 7.77% and 4.44% samples the copy number values were reduced by >0.5 log value, a figure that is considered clinically significant by physicians. CONCLUSION: The HIV-1 viral load assay reported in this study was found to be robust, reliable, economical and effective in resource limited settings such as those existing in India. PCR probes specially designed from HIV-1 Subtype C-specific nucleotide sequences originating from India imparted specificity towards such isolates and demonstrated superior results when compared to two similar commercial assays widely used in India.
Descritores: RNA Viral/sangue
Infecções por HIV/diagnóstico
HIV-1/isolamento & purificação
Carga Viral/métodos
-Compostos Orgânicos
Kit de Reagentes para Diagnóstico/economia
Sequência de Bases/genética
Genes gag/genética
Modelos Lineares
Sensibilidade e Especificidade
HIV-1/classificação
Estatísticas não Paramétricas
Gerenciamento Clínico
Limite de Detecção
Reação em Cadeia da Polimerase em Tempo Real
Invenções
Índia
Limites: Humanos
Tipo de Publ: Estudo de Validação
Responsável: CL1.1 - Biblioteca Central


  7 / 217 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Id: biblio-1093021
Autor: Musso, Carlos G; Restrepo-Valencia, César A.
Título: Arteriolopatía calcificante (calcifilaxis). Recomendaciones para su manejo / Calcific arteriolopathy (calciphylaxis). Recommendations for its management
Fonte: Rev. colomb. nefrol. (En línea);6(1):14-16, ene.-jun. 2019. tab.
Idioma: es.
Descritores: Calciofilaxia
Gerenciamento Clínico
-Colômbia
Calcificação Vascular
Nefrologia
Limites: Humanos
Masculino
Feminino
Tipo de Publ: Editorial
Responsável: CO661.9


  8 / 217 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Bocchi, Edimar Alcides
Almeida, Dirceu Rodrigues
Texto completo
Id: biblio-1153946
Autor: Bocchi, Edimar Alcides; Moreira, Henrique Turin; Nakamuta, Juliana Sanajotti; Simões, Marcus Vinicius; Casas, Alberto de Almeida Las; Costa, Altamiro Reis da; Assis, Amberson Vieira de; Durães, André Rodrigues; Pereira-Barretto, Antonio Carlos; Ravessa, Antonio Delduque de Araujo; Macedo, Ariane Vieira Scarlatelli; Biselli, Bruno; Pinto, Carolina Maria Nogueira; Filho, Conrado Roberto Hoffmann; Costantini, Costantino Roberto; Almeida, Dirceu Rodrigues; Santos Jr, Edval Gomes dos; Soliva Junior, Erwin; Figueiredo, Estevão Lanna; Albuquerque, Felipe Neves de; Paulitsch, Felipe; Neuenschwander, Fernando Carvalho; Figueiredo Neto, José Albuquerque de; Brito, Flavio de Souza; Lopes, Heno Ferreira; Villacorta, Humberto; Souza Neto, João David de; Sepulveda, João Mariano; Ayoub, José Carlos Aidar; Vilela-Martin, José F; Cardoso, Juliano Novaes; Uemura, Laercio; Moura, Lidia Zytynski; Maia, Lilia Nigro; Oliveira, Lucia Brandão de; Maia, Lucimir; Silva, Luís Beck da; Gowdak, Luís Henrique Wolff; Danzmann, Luiz Claudio; Andrade, Marcus; Braile-Sternieri, Maria Christiane Valeria Braga; Moreira, Maria da Consolação Vieira; França Neto, Olimpio R; Filho, Otavio Rizzi Coelho; Esteves, Paulo Frederico; Raupp-da-Rosa, Priscila; Silva, Ricardo Jorge de Queiroz e; Mourilhe-Rocha, Ricardo; Viégas, Ruy Felipe Melo; Rassi, Salvador; Mangili, Sandrigo; Kaiser, Sergio Emanuel; Martins, Silvia Marinho; Kawabata, Vitor Sergio.
Título: Implications for clinical practice from a multicenter survey of heart failure management centers
Fonte: Clinics;76:e1991, 2021. tab, graf.
Idioma: en.
Resumo: OBJECTIVES: This observational, cross-sectional study based aimed to test whether heart failure (HF)-disease management program (DMP) components are influencing care and clinical decision-making in Brazil. METHODS: The survey respondents were cardiologists recommended by experts in the field and invited to participate in the survey via printed form or email. The survey consisted of 29 questions addressing site demographics, public versus private infrastructure, HF baseline data of patients, clinical management of HF, performance indicators, and perceptions about HF treatment. RESULTS: Data were obtained from 98 centers (58% public and 42% private practice) distributed across Brazil. Public HF-DMPs compared to private HF-DMP were associated with a higher percentage of HF-DMP-dedicated services (79% vs 24%; OR: 12, 95% CI: 94-34), multidisciplinary HF (MHF)-DMP [84% vs 65%; OR: 3; 95% CI: 1-8), HF educational programs (49% vs 18%; OR: 4; 95% CI: 1-2), written instructions before hospital discharge (83% vs 76%; OR: 1; 95% CI: 0-5), rehabilitation (69% vs 39%; OR: 3; 95% CI: 1-9), monitoring (44% vs 29%; OR: 2; 95% CI: 1-5), guideline-directed medical therapy-HF use (94% vs 85%; OR: 3; 95% CI: 0-15), and less B-type natriuretic peptide (BNP) dosage (73% vs 88%; OR: 3; 95% CI: 1-9), and key performance indicators (37% vs 60%; OR: 3; 95% CI: 1-7). In comparison to non- MHF-DMP, MHF-DMP was associated with more educational initiatives (42% vs 6%; OR: 12; 95% CI: 1-97), written instructions (83% vs 68%; OR: 2: 95% CI: 1-7), rehabilitation (69% vs 17%; OR: 11; 95% CI: 3-44), monitoring (47% vs 6%; OR: 14; 95% CI: 2-115), GDMT-HF (92% vs 83%; OR: 3; 95% CI: 0-15). In addition, there were less use of BNP as a biomarker (70% vs 84%; OR: 2; 95% CI: 1-8) and key performance indicators (35% vs 51%; OR: 2; 95% CI: 91,6) in the non-MHF group. Physicians considered changing or introducing new medications mostly when patients were hospitalized or when observing worsening disease and/or symptoms. Adherence to drug treatment and non-drug treatment factors were the greatest medical problems associated with HF treatment. CONCLUSION: HF-DMPs are highly heterogeneous. New strategies for HF care should consider the present study highlights and clinical decision-making processes to improve HF patient care.
Descritores: Gerenciamento Clínico
Insuficiência Cardíaca/terapia
-Brasil
Estudos Transversais
Inquéritos e Questionários
Limites: Humanos
Tipo de Publ: Estudo Multicêntrico
Responsável: BR1.1 - BIREME


  9 / 217 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Chile
Texto completo
Id: biblio-899778
Autor: Rivera-Salgado, Daniel; Valverde-Muñoz, Kathia; Ávila-Agüero, María L.
Título: Neutropenia febril en niños con cáncer: manejo en el servicio de emergencias / Febrile neutropenia in cancer patients: management in the emergency room
Fonte: Rev. chil. infectol;35(1):62-71, 2018. tab.
Idioma: es.
Resumo: Resumen La neutropenia febril es una condición que puede amenazar la vida y que requiere de atención inmediata, particularmente en pacientes en que la misma está asociada a tratamientos con quimioterapia. Estos pacientes tienen un riesgo mucho mayor de desarrollar enfermedades bacterianas, y en ellos, la fiebre puede ser el único indicador de enfermedad bacteriana grave. El manejo adecuado de la neutropenia febril da énfasis en la identificación pronta de los pacientes, estratificación del riesgo y antibioterapia iniciada durante los primeros 60 min del ingreso al servicio de emergencias. No todos los niños con neutropenia febril conllevan el mismo riesgo de morbi-mortalidad, por lo que en los últimos años se han hecho esfuerzos para distinguir entre pacientes de alto riesgo en quienes se recomienda el manejo hospitalario más agresivo. En pacientes que se clasifican como de bajo riesgo se puede considerar el manejo ambulatorio inicial o después de 72 h, mientras que en aquellos de alto riesgo se recomienda hospitalizar y manejar con antimicrobianos parenterales.

Febrile neutropenia is a life-threatening condition that requires immediate attention, especially in patients with chemotherapy-related neutropenia. Patients with febrile neutropenia have a much greater risk of developing bacterial disease, and fever may be the only indicator of severe bacterial infection. Adequate management of febrile neutropenia emphasizes early recognition of patients, risk stratification, and antibiotic therapy administration during the first 60 minutes of admission to an emergency room. Not all children with febrile neutropenia carry the same risk of morbidity and mortality, so in recent years, efforts have been made to distinguish between high-risk patients where more aggressive hospital management is required. In children classified as low-risk, outpatient management may be considered initially or after 72 hours, whilst high-risk patients should be hospitalized and managed with parenteral antibiotics.
Descritores: Gerenciamento Clínico
Serviço Hospitalar de Emergência
Neutropenia Febril Induzida por Quimioterapia/diagnóstico
Neutropenia Febril Induzida por Quimioterapia/tratamento farmacológico
Antibacterianos/uso terapêutico
Neoplasias/tratamento farmacológico
-Fatores de Risco
Fatores Etários
Medição de Risco
Tempo para o Tratamento
Neutropenia Febril Induzida por Quimioterapia/etiologia
Neoplasias/complicações
Antineoplásicos/efeitos adversos
Limites: Humanos
Tipo de Publ: Revisão
Responsável: CL1.1 - Biblioteca Central


  10 / 217 LILACS  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
Id: biblio-1097192
Autor: Kopitowski, Karin; Mutchinick, Mercedes; Rubinstein, Esteban.
Título: ¿Podemos comenzar a cambiar nuestra "mirada" ante la urgencia hipertensiva? / Can we start changing our viewpoint towards hypertensive urgency?
Fonte: Evid. actual. práct. ambul;20(4):86-88, 2017. ilus.
Idioma: es.
Resumo: La urgencia hipertensiva (UH) es una situación muy frecuente que asusta tanto a los pacientes como a sus familiares y al personal de salud y representa aproximadamente el 30% de las consultas no programadas (o de urgencia). En el presente artículo, los autores se hacen eco de publicaciones recientes y proponen dejar de utilizar el término urgencia hipertensiva para describir las situaciones de elevación de la presión arterial por encima de una tensión arterial sistólica ≥ 180 mmHg y/o una tensión arterial diastólica (TAD) ≥ 110 mmHg, sin asociación con daño de órgano blanco (con o sin sintomatología inespecífica concurrente), ya que los pacientes con este cuadro no corren riesgo inminente, no requieren atención médica de urgencia y, por lo tanto, deberían enmarcarse dentro de los cuidados habituales de los pacientes con factores de riesgo cardiovascular y riesgo cardiovascular global elevado. Esto implica no solo un cambio semántico, sino un desafío en el abordaje y manejo de estas situaciones tan frecuentes. (AU)

Hypertensive urgency (UH) is a very frequent clinical situation that scares patients, their families as well as health care provid-ers and represents approximately 30% of the non-scheduled (or urgent) visits. In the present article, taking into account recent publications, the authors propose to stop using the term hypertensive urgency to describe situations of elevated blood pressure above systolic blood pressure ≥ 180 mmHg and / or diastolic blood pressure ( TAD) ≥ 110 mmHg, without end organ dam-age (with or without concurrent non-specific symptomatology), since patients with this condition are not at imminent risk, do not require urgent medical attention and should therefore be framed within usual care of patients with cardiovascular risk factors and high overall cardiovascular risk. This implies not only a semantic change, but a challenge in the approach and management of these frequent situations. (AU)
Descritores: Gerenciamento Clínico
Hipertensão/classificação
-Sinais e Sintomas
Doenças Cardiovasculares/classificação
Educação em Saúde/tendências
Educação de Pacientes como Assunto
Fatores de Risco
Emergências/classificação
Pressão Arterial
Promoção da Saúde/tendências
Hipertensão/prevenção & controle
Hipertensão/tratamento farmacológico
Anti-Hipertensivos/uso terapêutico
Limites: Humanos
Masculino
Feminino
Tipo de Publ: Editorial
Responsável: AR2.1 - Biblioteca Central



página 1 de 22 ir para página                         
   


Refinar a pesquisa
  Base de dados : Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde